Literature DB >> 22708558

Postprandial but not fasting insulin resistance is an early identifier of dysmetabolism in overweight subjects.

Rita S Patarrão1, W Wayne Lautt, Ricardo A Afonso, Rogério T Ribeiro, Ana B Fernandes, José M Boavida, M Paula Macedo.   

Abstract

The dynamic response to insulin is highly potentiated after meal ingestion, and this meal-induced insulin sensitization (MIS) in healthy subjects is dependent on cholinergic mechanisms. The main objective of this study was to test the hypothesis that the reduced response to insulin observed in moderately overweight subjects, in comparison with control lean subjects, is due to MIS impairment and not to a reduction in the direct hypoglycemic action of insulin. Both lean and overweight male subjects were recruited. Insulin sensitivity (IS) was assessed by the rapid insulin sensitivity test (RIST) performed after a 24 h fast, as well as after a standardized meal. Fasting glucose disposal was similar between lean and overweight subjects. Following the meal, glucose disposal increased more extensively in lean than overweight subjects. The insulin profiles, in both fasted and fed states, were superimposable, suggesting that the absence of a factor other than insulin is responsible for the decreased postprandial insulin sensitivity observed in overweight subjects. Our data suggest that in overweight subjects, MIS contribution is decreased, which is responsible for the postprandial impaired IS observed and is suggested to be the cause, not effect, of mild adiposity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22708558     DOI: 10.1139/y2012-086

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  2 in total

1.  Driver versus navigator causation in biology: the case of insulin and fasting glucose.

Authors:  Manawa Diwekar-Joshi; Milind Watve
Journal:  PeerJ       Date:  2020-12-11       Impact factor: 2.984

Review 2.  Obesity as an Early Symptom of the AMIS Syndrome.

Authors:  W Wayne Lautt; Hui Helen Wang
Journal:  J Clin Med       Date:  2014-10-28       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.